Nanotechnology may lead to new liver cancer treatmentFebruary 23rd, 2011 - 5:09 pm ICT by ANI
Washington, Feb 23 (ANI): A team of Penn State College of Medicine researchers has said that nanotechnology may open a new door on the treatment of liver cancer.
They used molecular-sized bubbles filled with chemotherapy drugs to prevent cell growth and initiate cell death in test tubes and mice.
Researchers evaluated the use of molecular-sized bubbles filled with C6-ceramide, called cerasomes, as an anti-cancer agent. Ceramide is a lipid molecule naturally present in the cell’s plasma membrane and controls cell functions, including cell aging, or senescence.
Hepatocellular carcinoma is the fifth most common cancer in the world and is highly aggressive. The chance of surviving five years is less than five percent, and treatment is typically chemotherapy and surgical management including transplantation.
“The beauty of ceramide is that it is non-toxic to normal cells, putting them to sleep, while selectively killing cancer cells,” said Mark Kester, Ph.D., G. Thomas Passananti Professor of Pharmacology.
Cerasomes, developed at Penn State College of Medicine, can target cancer cells very specifically and accurately, rather than affecting a larger area that includes healthy cells. The problem with ceramide is that as a lipid, it cannot be delivered effectively as a drug. To solve this limitation, the researchers use nanotechnology, creating the tiny cerasome, to turn the insoluble lipid into a soluble treatment.
“Cerasomes were designed as a therapeutic alternative to common chemotherapeutics,” said Kester. “These have been shown to be toxic to cancer cells and not to normal cells, and have already been shown to effectively treat cellular and animal models of breast cancer and melanoma. Cerasomes have also been shown to be essentially free of toxic side effects normally associated with anticancer agents.”
In the test tube and animal models of liver cancer, cerasomes, but not a placebo, selectively induced cell death in the cancer cells.
In mice with liver cancer, cerasomes blocked tumor vascularisation, the forming of blood vessels needed for growth and nutrition. Studies show that lack of nutrition causes cells to create more ceramide and leads to cell death.
“It is plausible that preventing liver tumor vascularization with cerasome treatment could induce widespread apoptosis, a genetically programmed series of events that leads to cell death in tumors,” Kester said. “The efficacy of our cerasomes in the treatment of diverse cancers lends significant therapeutic promise as it translates from bench to bedside.”
The researchers have published their work in the journal Gut. (ANI)
- 17-year-old mystery of 'starvation hormone' solved - Dec 27, 2010
- Protein that makes tumor cells in breast cancer resistant to treatments - Dec 15, 2010
- New discovery holds promise for liver cancer treatment - Mar 23, 2011
- Blue light could be highly in potent platinum-based cancer treatment - Dec 10, 2010
- New invention could improve cancer drug delivery - Dec 24, 2010
- New study paves way for better cancer treatment - Feb 05, 2011
- Papaya may harbour cancer cure - Mar 10, 2010
- Motor protein that blocks ovarian tumor growth found - Apr 27, 2011
- Nano drugs can kill skin, breast cancer cells - Dec 27, 2008
- Study shows that a new experimental cancer drug delays breast tumor growth - Jun 05, 2012
- Small molecules 'could block cell proliferation in cancerous human tumor' - Apr 14, 2011
- Latin brew bumps off colon cancer cells - Jan 24, 2012
- Viagra, anti-cancer drug combo shrinks tumors in vivo - Sep 28, 2010
- Overabundance of protein promotes growth of breast cancer stem cells - Feb 16, 2011
- Novel peptide 'kills' cancer cells more effective than current therapies - Jan 23, 2011
Tags: animal models, anticancer agents, breast cancer, cancer agent, cancer cell, cancer cells, cell death, cell functions, ceramide, chemotherapeutics, chemotherapy drugs, college of medicine, kester, liver cancer treatment, penn state college, penn state college of medicine, plasma membrane, test tubes, toxic side effects, treatment of liver cancer